The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
The example data, which was from an antidepressant clinical trial, can be found in DIA Missing Data webpage. Original data was from an antidepressant clinical trial with four treatments; two doses of an experimental medication, a positive control, and placebo. Hamilton 17-item rating scale for depression (HAMD17) was observed at baseline and its change scores at weeks 1, 2, 4, 6, and 8 ( Goldstein et al. 2004). To mask the real data Week-8 observations were removed. The example data is a sub-sample of the original data: two arms were created; the original placebo arm and a “drug arm” created by randomly selecting patients from the three non-placebo arms.
data(antidep)
head(antidep) %>% kbl(align = "c") %>%
kable_classic(full_width = F, html_font = "Cambria") %>%
column_spec(1:2, width = "2cm") %>%
add_header_above(c(" " = 1, " "=1, "Responses at the baseline, week 1, 2, 4, and 6" = 5))
Responses at the baseline, week 1, 2, 4, and 6 | ||||||
---|---|---|---|---|---|---|
PID | tx | y0 | y1 | y2 | y4 | y6 |
1503 | 1 | 32 | -11 | -12 | -13 | -15 |
1507 | 0 | 14 | -3 | 0 | -5 | -9 |
1509 | 1 | 21 | -1 | -3 | -5 | -8 |
1511 | 0 | 21 | -5 | -3 | -3 | -9 |
1513 | 1 | 19 | 5 | NA | NA | NA |
1514 | 0 | 21 | 2 | NA | NA | NA |
Missing pattern is displayed in the following plot:
The planned statistical method to analyze this endpoint was
mixed-effects model with last-observation-carry-forward (LOCF) as the
imputation method. In this example, missing values are imputed with GLM
models. This is implemented through family
argument, say,
family = gaussian()
(its default link is identity
). The same
imputation setting is applied for imputing y2
and y4
, i.e. argument
models
is set to be glm_gaussian_identity
. We run the GLM imputation
model with an adaptation of 10000 and 2000 iterations for 4 chains.
Chains run in parallel, which is set through doFuture
package:
registerDoFuture()
plan(multisession(workers = 4))
an.test = remiod(formula=y6 ~ tx + y0 + y1 + y2 + y4, data=antidep, family = gaussian(),
models = c(y2="glm_gaussian_identity",y4="glm_gaussian_identity"),
n.iter = 100000, n.chains = 4, n.adapt = 10000, thin=100,
algorithm = "jags", trtvar = 'tx', method="MAR", mess=TRUE, warn=FALSE)
plan(sequential)
The following plots show trace plots and the estimated intervals as
shaded areas under the posterior density curves for the parameters of
treatment variable tx
in imputation models:
The specified set of parameters can be submitted through argument
subset
with keyword selected_vars
(alternatively, keyword
selected_parms
can be used):
mcsub = get_subset(object = an.test$mc.mar, subset=c(selected_vars = list("tx")))
color_scheme_set("purple")
mcmc_trace(mcsub, facet_args = list(ncol = 1, strip.position = "left"))
mcmc_areas(
mcsub,
prob = 0.95, # 95% intervals
prob_outer = 0.99,
point_est = "mean"
)
To obtain jump-to-reference analysis, we extract MI data with
method="J2R"
, and pool analysis results with miAnalyze
:
j2r = extract_MIdata(object=an.test, method="J2R", M=1000, minspace=4)
res.j2r = miAnalyze(formula = y6 ~ y0 + tx, data = j2r, family = gaussian())
data.frame(res.j2r$Est.pool) %>% select(-6) %>%
mutate_if(is.numeric, format, digits=4,nsmall = 0) %>%
kbl(align = "c") %>%
column_spec(1:6, width = "3cm") %>%
kable_classic(full_width = F, html_font = "Cambria")
Estimate | SE | CI.low | CI.up | t | |
---|---|---|---|---|---|
(Intercept) | 1.0433 | 1.82704 | -2.5376 | 4.6243 | 0.5711 |
y0 | -0.3292 | 0.09697 | -0.5192 | -0.1391 | -3.3945 |
tx | -2.3558 | 1.04973 | -4.4133 | -0.2984 | -2.2442 |
Wang and Liu. 2022. “Remiod: Reference-Based Controlled Multiple Imputation of Longitudinal Binary and Ordinal Outcomes with Non-Ignorable Missingness.” arXiv 2203.02771.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.